Last reviewed · How we verify
ST-1898 tablets
At a glance
| Generic name | ST-1898 tablets |
|---|---|
| Sponsor | Beijing Scitech-Mq Pharmaceuticals Limited |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of ACC-1898 in Adult Participants With Advanced Solid Tumors (PHASE1)
- A Study of ST-1898 for Unresectable or Metastatic Melanoma (PHASE1, PHASE2)
- Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer (PHASE2)
- Study of ST-1898 in Advanced Renal Cell Carcinoma (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |